Literature DB >> 3734107

An enzyme-linked immunosorbent assay for the antineoplastic agent vincristine.

S P Lapinjoki, H M Veräjänkorva, A E Huhtikangas, T J Lehtola, M Lounasmaa.   

Abstract

An enzyme-linked immunosorbent assay for vincristine was developed, based on a new procedure for synthesizing the hapten-protein conjugate. In both the immunogen and the enzyme tracer a spacer group was introduced between the hapten and protein, and the vincristine was coupled at a site far from its functional groups. The antibody produced proved to be exceptionally specific as compared with previous immunoassays for bis-indole alkaloids. Thousandfold antibody dilutions could be used and samples at the femtomole range were assayable. Applications of the method to patient plasma samples and to plant material are described.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3734107     DOI: 10.1080/01971528608063049

Source DB:  PubMed          Journal:  J Immunoassay        ISSN: 0197-1522


  4 in total

1.  Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug.

Authors:  D Filipowska; T Filipowski; B Morelowska; W Kazanowska; T Laudanski; S Lapinjoki; M Akerlund; A Breeze
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Preclinical and clinical pharmacology of vinca alkaloids.

Authors:  X J Zhou; R Rahmani
Journal:  Drugs       Date:  1992       Impact factor: 9.546

3.  IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis.

Authors:  Christina Lückel; Felix Picard; Hartmann Raifer; Lucia Campos Carrascosa; Anna Guralnik; Yajuan Zhang; Matthias Klein; Stefan Bittner; Falk Steffen; Sonja Moos; Federico Marini; Renee Gloury; Florian C Kurschus; Ying-Yin Chao; Wilhelm Bertrams; Veronika Sexl; Bernd Schmeck; Lynn Bonetti; Melanie Grusdat; Michael Lohoff; Christina E Zielinski; Frauke Zipp; Axel Kallies; Dirk Brenner; Michael Berger; Tobias Bopp; Björn Tackenberg; Magdalena Huber
Journal:  Nat Commun       Date:  2019-12-16       Impact factor: 14.919

Review 4.  Progress in Immunoassays of Toxic Alkaloids in Plant-Derived Medicines: A Review.

Authors:  Zhenhui Ren; Huixia Zhang; Zile Wang; Xin Chen; Liu Yang; Haiyang Jiang
Journal:  Toxins (Basel)       Date:  2022-02-23       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.